165 related articles for article (PubMed ID: 10894045)
1. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
[TBL] [Abstract][Full Text] [Related]
2. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
3. [Neuroblastoma: biological markers, surgery, and clinical course].
Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
5. Nervous system-specific enolase in serum as a marker for neuroblastoma.
Ishiguro Y; Kato K; Ito T; Nagaya M; Yamada N; Sugito T
Pediatrics; 1983 Nov; 72(5):696-700. PubMed ID: 6356007
[TBL] [Abstract][Full Text] [Related]
6. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury.
Bandyopadhyay S; Hennes H; Gorelick MH; Wells RG; Walsh-Kelly CM
Acad Emerg Med; 2005 Aug; 12(8):732-8. PubMed ID: 16079426
[TBL] [Abstract][Full Text] [Related]
8. [Blood neuronal specific enolase in newborns with perinatal asphyxia].
Verdú Pérez A; Falero MP; Arroyos A; Estévez F; Félix V; López Y; Pantoja A; Ureta A
Rev Neurol; 2001 Apr 16-30; 32(8):714-7. PubMed ID: 11391504
[TBL] [Abstract][Full Text] [Related]
9. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma.
Zeltzer PM; Marangos PJ; Sather H; Evans A; Siegel S; Wong KY; Dalton A; Seeger R; Hammond D
Prog Clin Biol Res; 1985; 175():319-29. PubMed ID: 3991735
[No Abstract] [Full Text] [Related]
11. Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1.
Kotaska K; Petrak B; Kukacka J; Kraus J; Prusa R
Neuro Endocrinol Lett; 2007 Dec; 28(6):761-4. PubMed ID: 18063947
[TBL] [Abstract][Full Text] [Related]
12. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
13. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma in adults. Pathologic findings and clinical outcome.
Aleshire SL; Glick AD; Cruz VE; Bradley CA; Parl FF
Arch Pathol Lab Med; 1985 Apr; 109(4):352-6. PubMed ID: 3885899
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Geyer C; Ulrich A; Gräfe G; Stach B; Till H
J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
17. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?
Hero B; Graf N; Simon T; Weirich A; Tröger J; Berthold F
Klin Padiatr; 2002; 214(4):157-61. PubMed ID: 12165895
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
20. [Small cell carcinoma of the prostate. Description of a case].
Candura SM; Fonte R; Cantale G; Paolotti D; Biscaldi G
Recenti Prog Med; 2000 Nov; 91(11):567-70. PubMed ID: 11125949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
